tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Regenxbio files to sell 268,096 shares of common stock for holders
PremiumThe FlyRegenxbio files to sell 268,096 shares of common stock for holders
1M ago
Promising RGX-202 Trial Results Justify Buy Rating for RegenXBio Amid Market Skepticism
Premium
Ratings
Promising RGX-202 Trial Results Justify Buy Rating for RegenXBio Amid Market Skepticism
2M ago
Promising Interim Data and Accelerated Approval Pathway Drive Buy Rating for RegenXBio’s RGX-202
Premium
Ratings
Promising Interim Data and Accelerated Approval Pathway Drive Buy Rating for RegenXBio’s RGX-202
2M ago
RegenXBio Secures $250M Royalty Monetization Deal
PremiumCompany AnnouncementsRegenXBio Secures $250M Royalty Monetization Deal
2M ago
Regenxbio signs strategic royalty monetization agreement for up to $250M
Premium
The Fly
Regenxbio signs strategic royalty monetization agreement for up to $250M
2M ago
REGENXBIO’s Earnings Call Highlights Strong Start to Fiscal Year
Premium
Company Announcements
REGENXBIO’s Earnings Call Highlights Strong Start to Fiscal Year
2M ago
Optimistic Buy Rating for RegenXBio Amidst Promising Gene Therapy Developments and Financial Prospects
PremiumRatingsOptimistic Buy Rating for RegenXBio Amidst Promising Gene Therapy Developments and Financial Prospects
2M ago
REGENXBIO Reports Strong Q1 2025 Financial Results
Premium
Company Announcements
REGENXBIO Reports Strong Q1 2025 Financial Results
2M ago
Regenxbio reports Q1 EPS 12c vs. ($1.38) last year
Premium
The Fly
Regenxbio reports Q1 EPS 12c vs. ($1.38) last year
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100